Results 1 to 10 of about 43,474 (218)
Thrombotic thrombocytopenic purpura [PDF]
Medicina Universitaria, 2015 Thrombotic thrombocytopenic purpura (TTP) is a disease with a high rate of mortality if a proper treatment is not instated. Plasmapheresis with plasmatic exchange is the treatment of choice. Diagnosis is performed demonstrating microangiopathic hemolytic
Gómez Almaguer, David +2 more
core +4 more sources
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intolerance. [PDF]
Br J HaematolThe use of rituximab as a pre‐emptive treatment in immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is the current standard of care. However, for patients refractory to rituximab or for those with contraindication, further treatment guidelines are scarce.
Weisinger J +4 more
europepmc +2 more sources
Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy. [PDF]
Int J Rheum DisABSTRACT Introduction This study examined the efficacy and safety of Rituximab (RTX) treatment in connective tissue disease (CTD)‐associated thrombocytopenic purpura (TTP) and thrombotic microangiopathy (TMA), using historical controls as comparators.
Ohkubo N +7 more
europepmc +2 more sources
Improvement of thrombocytopenia after treatment for Helicobacter pylori in a patient with immunologic thrombocytopenic purpura [PDF]
Revista Brasileira de Hematologia e Hemoterapia, 2014 Immune thrombocytopenic purpura is the most common autoimmune hematologic disease, affecting individuals of different ages. Recently, the bacterium Helicobacter pylori entered the list of causes of immune thrombocytopenic purpura.
Aline Maia Rocha +2 more
doaj +3 more sources
Novel Mutation of Upshaw-Schulman Syndrome Associated with Coarctation of Aorta in Palestinian Child [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2020 Upshaw-Schulman syndrome is a rare inherited form of thrombotic thrombocytopenic purpura disease caused by deficiency of ADAMTS13 and reversible by fresh frozen plasma infusions.
Mahdi Zaid +5 more
doaj +1 more source
Journal of Medical Case Reports, 2023 Background Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura are both causes of thrombocytopenia. Recognizing thrombotic thrombocytopenic purpura is crucial for subsequent treatment and prognosis.
Hung-Chen Lin +6 more
doaj +1 more source
Journal of International Medical Research, 2022 A 33-year-old Chinese woman with a history of immune thrombocytopenic purpura presented with heavy menstrual bleeding. She was found to have thrombocytopenia, plasma ADAMTS13 activity of 0%, and positivity for the plasma ADAMTS13 inhibitor.
Hangping Ge +7 more
doaj +1 more source
Frontiers in Immunology, 2022 For patients with autoimmune diseases, vaccination is controversial. The use of vaccination in patients with autoimmune diseases is controversial. There are many reports of secondary thrombotic thrombocytopenic purpura cases after various vaccinations ...
Yanming Cui, Jianbo Wei, Xiang Peng
doaj +1 more source
Immune thrombocytopenic purpura [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2019 Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia (platelet count
Abir Zainal, Amr Salama, Richard Alweis
openaire +4 more sources
Thrombotic thrombocytopenic purpura [PDF]
Nature Reviews Disease Primers, 2017 Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is characterized by the concomitant occurrence of often severe thrombocytopenia, microangiopathic haemolytic anaemia and a variable degree of ischaemic organ damage, particularly affecting the brain, heart and kidneys.
Kremer Hovinga, Johanna A. +5 more
openaire +6 more sources